Literature DB >> 8515121

Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidémiologie clinique du SIDA en aquitaine.

A M Rogues, M Dupon, J Ladner, J M Ragnaud, J L Pellegrin, F Dabis.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8515121     DOI： 10.1093/infdis/168.1.245

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Herpes zoster and the stage and prognosis of HIV-1 infection.

Authors:  A McNulty; Y Li; U Radtke; J Kaldor; R Rohrsheim; D A Cooper; B Donovan
Journal:  Genitourin Med       Date:  1997-12

2.  Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.

Authors:  J W Gnann; C S Crumpacker; J P Lalezari; J A Smith; S K Tyring; K F Baum; M J Borucki; W P Joseph; G J Mertz; R T Steigbigel; G A Cloud; S J Soong; L C Sherrill; D A DeHertogh; R J Whitley
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Prevalence of shingles and its association with PTSD among HIV-infected women in Rwanda.

Authors:  Jean d'Amour Sinayobye; Donald R Hoover; Qiuhu Shi; Eugene Mutimura; Hillel W Cohen; Kathryn Anastos
Journal:  BMJ Open       Date:  2015-03-06       Impact factor: 2.692

4.  Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.

Authors:  Elchonon M Berkowitz; Graeme Moyle; Hans-Jürgen Stellbrink; Dirk Schürmann; Stephen Kegg; Matthias Stoll; Mohamed El Idrissi; Lidia Oostvogels; Thomas C Heineman
Journal:  J Infect Dis       Date:  2014-11-03       Impact factor: 5.226

5.  Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.

Authors:  Mathieu Nacher; Celia Basurko; Antoine Adenis; Emilie Gaubert-Marechal; Emilie Mosnier; Sophie Edouard; Vincent Vantilcke; Sindou Sivapregassam; Benoit Tressières; André Cabié; Pierre Couppié
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.